Clinical Trial Update: Liposomal Bupivacaine in Adductor Canal Blocks (ACB) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating liposomal bupivacaine in adductor canal blocks for arthroplasty complications has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroplasty Complications
• Peripheral Nerve Block Complications

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Miami | Conditions: Arthroplasty Complications, Adductor Canal Block | Phase 4 | Status: WITHDRAWN